RCKTW ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM)
- 0.053
- -0.004-7.34%
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
4: Statement of changes in beneficial ownership of securities-Director Bjork Elisabeth
4: Statement of changes in beneficial ownership of securities-Director Makker Gotham
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Director Dolsten Mikael
3: Initial statement of beneficial ownership of securities-Director Dolsten Mikael
4: Statement of changes in beneficial ownership of securities-Officer Wilson Martin
4: Statement of changes in beneficial ownership of securities-Officer Shah Gaurav
4: Statement of changes in beneficial ownership of securities-Officer Patel Kinnari
4: Statement of changes in beneficial ownership of securities-Officer Militello John
S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
10-Q: Q2 2024 Earnings Report
8-K: Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
4: Statement of changes in beneficial ownership of securities-Officer Militello John
144: Notice of proposed sale of securities pursuant to Rule 144